Caniverm Tablets 0.7g - 100 Tablets

Caniverm Tablets 0.7g

Active substances: Fenbendazole, Pyrantel, and Praziquantel
A highly effective medication against roundworms and tapeworms in dogs, cats, canines, and felines.
The smooth surface and ideal shape ensure easy swallowing.
To meet the demands of the veterinary market, two tablet sizes and three different packaging options have been specially designed, in compliance with legal requirements.

COMPOSITION – active substances:
1 tablet – 0.7g:
Fenbendazole 150 mg, Pyrantel embonate 144 mg, Praziquantel 50 mg

1 tablet – 0.175g:
Fenbendazole 37.5 mg, Pyrantel embonate 36 mg, Praziquantel 12.5 mg

FORM OF MEDICATION:
Tablets

PHARMACOLOGICAL PROPERTIES:
Fenbendazole, administered orally, reaches the parasites and blocks the polymerization of the structural protein tubulin in the axons of nerve cells, interfering with the transport function of the parasite's absorption cells. Fenbendazole belongs to the group of benzimidazole derivatives. It has a broad spectrum of action against nematodes, lungworms, certain tapeworms, and cestodes. It acts against mature and developing forms of sensitive intestinal worms.
Pyrantel pamoate acts as a nicotinic cholinergic antagonist in ganglia, causing spastic neuro-muscular paralysis in the parasite. It is highly effective against infections caused by Toxocara canis, Toxocara cati, Toxascaris leonina, Uncinaria stenocephala, and Ancylostoma caninum. However, it has limited action against N. americanus and does not affect trichurosis or strongyloidiasis. Pyrantel does not have vermicidal or ovicidal properties.
Praziquantel, a synthetic derivative of isoquinoline-pyrazine, increases calcium ion permeability in the parasite's cell membranes, leading to muscle contractions, paralysis, and death. It acts against both immature and mature stages of parasites. The combination of febantel and pyrantel pamoate enhances deworming effectiveness, achieving more than 90% efficiency.

INDICATIONS:
For parasitic infections caused by roundworms and tapeworms in dogs, cats, felines, and canines (Toxocara canis, Toxocara cati, Toxascaris leonina, Taenia spp., Trichuris vulpis, Uncinaria stenocephala, Ancylostoma caninum, Echinococcus granulosus, Echinococcus multilocularis, Dipylidium caninum, Multiceps multiceps, Mesocestoides spp.)

CONTRAINDICATIONS:
Ocular cysticercosis and spinal neurocysticercosis. Liver disorders.

SIDE EFFECTS:
Vomiting and hives may occur a few hours after administration due to the proteins released from dead parasites, not as a reaction to the medication. The product may cause lethargy in animals.

INTERACTIONS:
Should not be administered simultaneously with piperazine-based preparations or other antiparasitic agents.

ADMINISTRATION ROUTE:
Oral. The tablets can be given separately or mixed with food. A single dose is administered. It should not be given with dairy products. For felines and canines in zoos, circuses, etc., the product should be given in crushed form, incorporated into pieces of meat, and provided in the morning feed according to the number of animals.

PRECAUTIONS:
For pregnant females, the appropriate dosage must be calculated. It is recommended to administer the product to puppies starting at 3 weeks of age and then regularly every 3 months.

DOSAGE:

• Puppies, small dogs, and cats:
  1 tablet 0.175g per 0.5 – 2 kg body weight
  ½ tablet 0.7g or 2 tablets 0.175g per 2 – 5 kg body weight
• Medium-sized dogs:
  1 tablet 0.7g or 4 tablets 0.175g per 5 – 10 kg body weight
• Large dogs or large carnivores:
  1 tablet 0.7g per 10 kg body weight

WITHDRAWAL PERIOD:
The product is not intended for consumption animals.

PACKAGING:

• Tablets 0.7g: 1 box of 6 tablets; 1 box of 100 tablets
• Tablets 0.175g: 1 box of 6 tablets

STORAGE:
Store in a dry and dark place, in the original packaging, at a temperature of up to 25ºC. Keep away from light.